CONCORD BIOTECH LIMITED UNIT-III

CONCORD BIOTECH LIMITED UNIT-III is a factory (manufacturer). Company Introduction:

CONCORD BIOTECH LIMITED UNIT-III is a manufacturing facility (factory) that is part of Concord Biotech Limited, a prominent Indian biopharmaceutical company. But Concord Biotech Limited specializes in the research, research, manufacturing, and marketing of fermentation-based Active medical Ingredients (APIs) and finished formulations. Based on my observations, The company is recognized as a global player in niche fermentation items, with a strong focus on therapeutic areas such as immunosuppressants, oncology, anti-fungals, and critical care. UNIT-III represents one of Concord Biotech's dedicated production vegetation, underscoring its role as a manufacturing site responsible to the manufacturing-scale production of medical items. And The company is distinguished by its robust research and research capabilities, cutting-edge manufacturing infrastructure, and unwavering commitment to condition standards, serving both domestic and international markets. Therefore, CONCORD BIOTECH LIMITED UNIT-III is unequivocally a factory involved in the production of biopharmaceutical items.

Concord Biotech Limited Unit-III manufactures or sells the following products:

* Mupirocin

* Sirolimus

* Tacrolimus

* Mycophenolate mofetil

* Pimecrolimus

* Voclosporin

* Everolimus

* Clindamycin

* A variety of other fermentation and chemical synthesis-based APIs.